title: Is the therapeutic action of sildenafil mediated partly through the inhibition of superoxide formation?
authors.affiliation: Bristol Heart Institute and Department of Urology, Bristol Royal Infirmary, UK.
authors.forename: Jamie Y
authors.initials: JY
authors.lastname: Jeremy
authors.forename: Anthony
authors.initials: A
authors.lastname: Koupparis
authors.forename: Saima
authors.initials: S
authors.lastname: Muzaffar
authors.forename: Raj
authors.initials: R
authors.lastname: Persad
authors.forename: Gianni D
authors.initials: GD
authors.lastname: Angelini
authors.forename: Nilima
authors.initials: N
authors.lastname: Shukla
mesh_terms: D004347:Drug Interactions; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D013481:Superoxides / Q000378:metabolism*
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D013481:Superoxides; D009569:Nitric Oxide; D000068677:Sildenafil Citrate